Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
about
Glutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1)Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial.Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.Sulfur amino acid-free diet results in increased glutamate in human midbrain: a pilot magnetic resonance spectroscopic study.Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.Molecular pathways and genetic aspects of Parkinson's disease: from bench to bedside.Impaired glutathione synthesis in neurodegeneration.Serum uric acid levels in Parkinson's disease and related disorders.Neurochemical and motor changes in mice with combined mutations linked to Parkinson's disease.Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.Targeting urate to reduce oxidative stress in Parkinson disease.Low serum uric acid levels in progressive supranuclear palsy.Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.Serum uric acid in patients with Parkinson's disease and vascular parkinsonism: a cross-sectional study.Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway.Oxytosis/Ferroptosis-(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System.Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaineThe effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats
P2860
Q28085756-6B80BCA0-0028-4836-8B45-503609B241F0Q34101885-3E538026-F21A-43FC-A323-5BEE3C4703B2Q34629589-2C35D15F-E58D-40AB-AA1F-4EF3D8CA02A3Q35740204-7AE9CBF2-494A-4170-95DD-3FDF4CD8EC78Q36590693-B3EE4E2F-9BA5-4519-8044-947AA09E1D16Q37021321-9344FB7D-C957-43CD-83A5-65EE14E9C549Q37291406-D37D3343-233A-4B60-B5A5-6C84930DEAD5Q37599658-5CB7040A-2320-4C80-94F8-18A87DED7AA5Q37669523-B62DE59D-4B32-4204-9B6E-BE92E6E4C5E4Q39019452-212EC50C-59FE-4539-A83F-EDFF0E256E89Q39379023-35164C35-6DB3-45B3-B89D-146C35A0C18AQ40190481-8EEB3662-0580-48D5-8D39-8C2DE6D8FD05Q41662736-AF1BBA3C-71B3-4863-A89F-D02B8E11FAE1Q42478312-A2008084-9E28-4A52-B509-BFD40B386D80Q48212390-F8A0036C-7141-4806-AA83-79EE950D9A5AQ48323370-3D431460-B11D-4CC2-A1F4-0842443C113AQ54946045-F3F8CE83-8E0B-42FD-A340-4A18DF82965EQ57163350-AFA48C5A-5B75-44CC-8426-5189F6D5C145Q57729879-1419100A-94EF-4545-A2C4-61DC84474FD3
P2860
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
@en
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
@nl
type
label
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
@en
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
@nl
prefLabel
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
@en
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
@nl
P2093
P356
P1433
P1476
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
@en
P2093
Ali H Rajput
Mark Guttman
Stephen J Kish
Yoshiaki Furukawa
P304
P356
10.1002/MDS.10486
P407
P577
2003-09-01T00:00:00Z